1Anraku M, Kitamura K, Shinohara A, et al. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int, 2004, 66:841 - 844.
2National Kidney Foudation-Dialysis Outcomes Quality Initiative: NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease: Update 2000. Am J Kidney Dis, 2001, 37(Suppl) : 182 - 123.
3Macdougall IC, Tucker B, Thompson J, et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int, 1996, 50:1694 - 1699.
4Taylor JE, Peat N, Porter C, et al. Regular, Low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients. Nephrol Dial Transplant, 1996, 11:1079 - 1083.
5An G, Stefan S. Has the time come to use antioxidant therapy in uraemic patients. Nephro Dial Transplant, 2003, 18:1452 - 1455.
5Anraku M, Kitamura K, Shinohara A, et al. Intravenous iron administra- tion induces oxidation of serum albumin in hemodialysispatients. Kidney Int ,2004,66:841-844.
